FRIEDL-NADERER JOHANNA (Chief Commercial Officer) sold 0.1% of their position (228.00 shares) of DYNE THERAPEUTICS, INC. on the open market
Open‑market sale worth $4.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/14/2026ACC: 0001193125-26-223984
Officer· Chief Commercial Officer
Since Mar 2026
-228.00
Net shares
Net seller
$4.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
228.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−228.00
Price / share
$18.36
Trade value
$4.19K
% of position
0.1%
5/13/2026
154.58K→154.35K
Total
Net shares
−228.00
Net value
-$4.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2026 | S · Sale | −228.00 | $18.36 | $4.19K | 0.1% | 154.58K | 154.35K |
| Total | −228.00 | -$4.19K | ||||||
Derivative Transactions0
No derivative transactions reported